Efficacy, pharmacokinetics and tolerability of a somatostatin analogue (L-363, 586) in insulin-dependent diabetes mellitus
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 38 (24), 2211-2219
- https://doi.org/10.1016/0024-3205(86)90573-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- A super active cyclic hexapeptide analog of somatostatinLife Sciences, 1984
- Somatostatin Half-Life: A Case Report in One Healthy Volunteer and a Three Month Follow-UpHormone and Metabolic Research, 1981
- Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*Journal of Clinical Endocrinology & Metabolism, 1979
- Treatment of Bleeding Esophageal Varices with SomatostatinNew England Journal of Medicine, 1978
- Hyperglucagonemia and Its SuppressionNew England Journal of Medicine, 1978
- Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitusDiabetologia, 1977
- INFLUENCE OF SOMATOSTATIN ON CARBOHYDRATE DISPOSAL AND ABSORPTION IN DIABETES MELLITUSThe Lancet, 1976
- Peptic ulcer in diabetes mellitusGastroenterologia Japonica, 1976
- A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated PatientsDiabetes, 1973
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973